Clinical trials
Active, not recruiting Glioblastoma trials in Russia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
2 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Blokhin's Russian Cancer Research Center | 1 |
| Novartis Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Astrocytoma | 2 |
| Glioblastoma | 2 |
| Glioma | 2 |
| Ganglioglioma | 1 |
| Ganglioneuroma | 1 |
| Histiocytosis, Langerhans-Cell | 1 |
| Neuroblastoma | 1 |
| Neurocytoma | 1 |
| Neurofibroma, Plexiform | 1 |
| Neurofibromatosis 1 | 1 |
Trials
Showing 1 to 2 of 2. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.